Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Bardone MR, et al. Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization. J. Antibiot. 31: 170-177, 1978. PubMed: 649512
Parenti F, et al. Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. I. Description of the producer strain, fermentation studies and biological properties. J. Antibiot. 31: 276-283, 1978. PubMed: 659325
Borghi A, et al. Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin). J. Antibiot. 37: 615-620, 1984. PubMed: 6235204
Cavalleri B, et al. Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VIII. Opening of the polypeptide chain of teicoplanin aglycone under hydrolytic conditions. J. Antibiot. 40: 49-59, 1987. PubMed: 2951359
Chung SK, et al. Biosynthetic studies of aridicin antibiotics. I. Labeling patterns and overall pathways. J. Antibiot. 39: 642-651, 1986. PubMed: 3733513
Chung SK, et al. Biosynthetic studies of aridicin antibiotics. II. Microbial transformations and glycosylations by protoplasts. J. Antibiot. 39: 652-659, 1986. PubMed: 3733514
Ito T, et al. A novel beta-lactamase inhibitor, SF-2103A produced by a Streptomyces. J. Antibiot. 35: 533-535, 1982. PubMed: 6980216
Beretta G, et al. Antibiotic substances. US Patent 4,239,751 dated Dec 16 1980
Nucleotide (GenBank) : X84647 A.teichomyceticus leuC and leuD genes.
